The majority of GLP-1s are produced by L-cells lining the small intestine and colon
Overall, the reduction was modest but meaningful at the population level, amounting to about 7 fewer cases of any substance use disorder (including nicotine) for every 1,000 people treated
A., Lam, M., Allen, B., Shariff, S
elegans by regulating the mTOR signaling pathway and suppressing the release of CCL11 cytokines, which are connected to age-related cellular and tissue impairments (Thakkar et al., 2013
GLG retrieved the main articles included in the review
By bridging these gaps, GLP-1RAs could herald a new era in pain management, offering hope for patients with refractory or complex pain conditions